Catalyzing RNA

By Sean P. Ryder Catalyzing RNA Finding hidden ribozymes in eukaryotic genomes 3D structure of a hammerhead ribozyme Cossa Giacomo / pdb file 1RMN Once thought to be a biological rarity, self-cleaving RNA enzymes—ribozymes—are being discovered in increasing numbers, thanks to new search tools. Now, in addition to studying their unusual chemical properties, scientists will be able to identify ribozymes in useful

Written bySean P. Ryder
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Once thought to be a biological rarity, self-cleaving RNA enzymes—ribozymes—are being discovered in increasing numbers, thanks to new search tools. Now, in addition to studying their unusual chemical properties, scientists will be able to identify ribozymes in useful model organisms; bringing the field one step closer to defining whether these catalytic RNAs have a broad function in gene regulation.

Ribozymes were first identified as “selfish” genetic elements—genes that replicate themselves apart from usual cellular mechanisms, often harming the host cell—such as the genetic material found in viruses and satellite plasmids. This suggests that ribozymes are remnants of an evolutionary era predominated by RNA life forms. Researchers have been able to artificially evolve new RNA catalysts in the lab, demonstrating that they should be able to arise quite readily,1 but the slow rate of discovery of naturally occurring ribozymes suggested that ribozymes may actually be quite rare—curiosities of unusual biological systems ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies